Related Experiment Videos

MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy

G Grandaliano1, L Gesualdo, F Bartoli

  • 1Division of Nephrology, Department of Emergency and Transplantation University of Bari, Italy.

Abstract

Insights

Monocyte chemotactic peptide-1 (MCP-1) and epidermal growth factor (EGF) are key in obstructive nephropathy. Their urinary levels can predict kidney damage and recovery after surgery.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Urology

Background:

  • Obstructive nephropathy exhibits tubular atrophy and interstitial monocyte infiltration.
  • Molecular mechanisms driving these changes are not well understood.
  • Epidermal growth factor (EGF) influences tubular cell growth, while monocyte chemotactic peptide-1 (MCP-1) attracts monocytes.

Purpose of the Study:

  • To investigate the roles of EGF and MCP-1 in congenital ureteropelvic junction obstruction (UPJO).
  • To assess urinary EGF and MCP-1 levels as potential biomarkers for UPJO severity and prognosis.

Main Methods:

  • Studied 24 patients with congenital UPJO and 15 healthy children.
  • Measured urinary EGF and MCP-1 levels using ELISA.
  • Evaluated EGF and MCP-1 gene expression in kidney biopsies via in situ hybridization.

Main Results:

  • UPJO kidneys showed increased MCP-1 and decreased EGF gene expression, correlating with monocyte infiltration and tubular damage.
  • Urinary MCP-1 was elevated, while EGF was reduced in UPJO patients.
  • Urinary MCP-1 correlated inversely with kidney function (MAG3 clearance).
  • Recurrent UTIs were linked to higher MCP-1 and lower EGF excretion.
  • Post-surgery, improved renal function was associated with normalized MCP-1 and EGF levels.

Conclusions:

  • MCP-1 and EGF are implicated in the tubulointerstitial damage of obstructive nephropathy.
  • Urinary excretion of MCP-1 and EGF may serve as valuable prognostic markers for congenital obstructive nephropathy.

Related Concept Videos